Home > Insider Trading > Filing (0001209191-18-047607)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1108109	Community Health Systems Inc	CYH	Services-General Medical & Surgical Hospitals, Nec (8062)	133893191

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1665775	Paul Patton Smith	4000 Meridian Boulevard Franklin TN 37067	Division President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-08-20	10,000	$3.51	103,417	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (Right to Buy)	$30.32	2011-02-24	2020-02-23	1,000	1,000	Direct
Common Stock	Stock Options (Right to Buy)	$34.38	2012-02-23	2021-02-22	1,000	1,000	Direct
Common Stock	Stock Options (Right to Buy)	$17.49	2013-02-16	2022-02-15	1,000	1,000	Direct
Common Stock	Performance Based Restricted	$0.00	2020-03-01	2027-02-28	20,000	20,000	Direct
Common Stock	Performance Based Restricted	$0.00	2021-03-01	2028-02-28	30,000	30,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2020-02-23	1,000	1,000	Direct
2021-02-22	1,000	1,000	Direct
2022-02-15	1,000	1,000	Direct
2027-02-28	20,000	20,000	Direct
2028-02-28	30,000	30,000	Direct

Footnotes

These shares were purchased in a series of transactions at a weighted average purchase price of approximately $3.513 per share.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between January 1, 2017 and December 31, 2019 (the "2017-2019 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the applicable performance objectives will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the 2017-2019 Performance Period.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between January 1, 2018 and December 31, 2020 (the "2018-2020 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the applicable performance measures will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the 2018-2020 Performance Period.